Funding Rounds
Translate Bio Series C round, January 10, 2017
Translate BioTranslate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
Summary
Stage: Series C
Raised Amount: $51.00M
Raised Date: 2017-01-10